Literature DB >> 16920327

Magnetic resonance imaging in breast cancer.

M Van Goethem1, W Tjalma, K Schelfout, I Verslegers, I Biltjes, P Parizel.   

Abstract

AIM: Due to its high sensitivity, magnetic resonance (MR) mammography is increasingly used as adjunct to mammography and ultrasound. The technique, however, has a relatively limited specificity. Therefore, it may only be used for specific indications. One of the indications is preoperative staging of breast carcinoma. This review serves to give an overview of the studies published on the role of MR in preoperative local staging.
METHODS: We reviewed studies of the role of MR mammography in the detection of breast carcinomas and in the assessment of the diameter and extent of carcinomas. We also reviewed published studies on detection of multifocal and multicentric carcinomas that were occult on mammography and ultrasound. Advantages and drawbacks of preoperative MR mammography and the effect on treatment, as reported in different published studies, are described. The review is based on a search of PubMed, using specific terms for the different topics.
RESULTS: MR has the highest sensitivity to detect invasive carcinomas and is best in assessment of tumor extent, including detection of multifocal, multicentric and bilateral disease.
CONCLUSION: MR mammography is a valuable adjunct to conventional imaging in the preoperative local staging of breast cancer.

Entities:  

Mesh:

Year:  2006        PMID: 16920327     DOI: 10.1016/j.ejso.2006.06.009

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  20 in total

1.  Incremental value of magnetic resonance imaging for breast surgery planning.

Authors:  Sibel Ozkan Gurdal; Beyza Ozcinar; Munire Kayahan; Abdullah Igci; Mehtap Tunaci; Vahit Ozmen; Gulden Acunas; Ekrem Yavuz; Mustafa Kecer; Mahmut Muslumanoglu
Journal:  Surg Today       Date:  2013-01       Impact factor: 2.549

Review 2.  Combined PET/MRI: a new dimension in whole-body oncology imaging?

Authors:  Gerald Antoch; Andreas Bockisch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

3.  Segmental enhancement on breast MR images: differential diagnosis and diagnostic strategy.

Authors:  Sachiko Yuen; Takayoshi Uematsu; Kasami Masako; Yoshihiro Uchida; Tsunehiko Nishimura
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

4.  Whole-body hybrid PET/MRI: ready for clinical use?

Authors:  Osman Ratib; Thomas Beyer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06       Impact factor: 9.236

Review 5.  Assessment of grating-based X-ray phase-contrast CT for differentiation of invasive ductal carcinoma and ductal carcinoma in situ in an experimental ex vivo set-up.

Authors:  Anikó Sztrókay; Julia Herzen; Sigrid D Auweter; Susanne Liebhardt; Doris Mayr; Marian Willner; Dieter Hahn; Irene Zanette; Timm Weitkamp; Karin Hellerhoff; Franz Pfeiffer; Maximilian F Reiser; Fabian Bamberg
Journal:  Eur Radiol       Date:  2012-08-31       Impact factor: 5.315

6.  Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging.

Authors:  Wei Huang; Luminita A Tudorica; Xin Li; Sunitha B Thakur; Yiyi Chen; Elizabeth A Morris; Ian J Tagge; Maayan E Korenblit; William D Rooney; Jason A Koutcher; Charles S Springer
Journal:  Radiology       Date:  2011-08-09       Impact factor: 11.105

7.  Diagnostic accuracy of fused positron emission tomography/magnetic resonance mammography: initial results.

Authors:  T A Heusner; S Hahn; C Jonkmanns; S Kuemmel; F Otterbach; M E Hamami; A R Stahl; A Bockisch; M Forsting; G Antoch
Journal:  Br J Radiol       Date:  2010-10-19       Impact factor: 3.039

8.  Preoperative MRI of the breast (POMB) influences primary treatment in breast cancer: a prospective, randomized, multicenter study.

Authors:  Virginia Gonzalez; Kerstin Sandelin; Anders Karlsson; Wiveca Åberg; Lars Löfgren; Gabriela Iliescu; Staffan Eriksson; Brita Arver
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

Review 9.  Theranostic Advances in Breast Cancer in Nuclear Medicine.

Authors:  Nasim Vahidfar; Ayuob Aghanejad; Hojjat Ahmadzadehfar; Saeed Farzanehfar; Elisabeth Eppard
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

Review 10.  PET/MR: a paradigm shift.

Authors:  Florian C Gaertner; Sebastian Fürst; Markus Schwaiger
Journal:  Cancer Imaging       Date:  2013-02-27       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.